Group 5D: Triple Negative & Pan-Cancers; Immunotherapy; Real-World Data/Outcomes; Treatment Resistance

Poster #6617: Effects of concomitant gut-microbiome altering medications on immune checkpoint inhibitors therapy: A retrospective study

Poster #1088: ARID1A deficiency in triple-negative breast cancer induces adaptive immune resistance and sensitivity to immune checkpoint inhibitors